{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:50:26Z","timestamp":1779205826708,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Young Elite Scientists Sponsorship Program by Henan Association for Science and Technology","award":["NO.2022HYTP043"],"award-info":[{"award-number":["NO.2022HYTP043"]}]},{"name":"Key Project of Henan Medical Science & Technology","award":["2020zd-02"],"award-info":[{"award-number":["2020zd-02"]}]},{"name":"Investigation Project of Social Science Circles Federation of Henan Province","award":["No.SL;-2023-1363"],"award-info":[{"award-number":["No.SL;-2023-1363"]}]},{"name":"the Joint Project of Henan Medical Science & Technology","award":["NO.LHGI20230060"],"award-info":[{"award-number":["NO.LHGI20230060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pheochromocytoma\/paraganglioma (PGPG) is a rare neuroendocrine tumor. Amino acid metabolism is crucial for energy production, redox balance, and metabolic pathways in tumor cell proliferation. This study aimed to build a risk model using amino acid metabolism-related genes, enhancing PGPG diagnosis and treatment decisions. We analyzed RNA-sequencing data from the PCPG cohort in the GEO dataset as our training set and validated our findings using the TCGA dataset and an additional clinical cohort. WGCNA and LASSO were utilized to identify hub genes and develop risk prediction models. The single-sample gene set enrichment analysis, MCPCOUNTER, and ESTIMATE algorithm calculated the relationship between amino acid metabolism and immune cell infiltration in PCPG. The TIDE algorithm predicted the immunotherapy efficacy for PCPG patients. The analysis identified 292 genes with differential expression, which are involved in amino acid metabolism and immune pathways. Six genes (DDC, SYT11, GCLM, PSMB7, TYRO3, AGMAT) were identified as crucial for the risk prediction model. Patients with a high-risk profile demonstrated reduced immune infiltration but potentially higher benefits from immunotherapy. Notably, DDC and SYT11 showed strong diagnostic and prognostic potential. Validation through quantitative Real-Time Polymerase Chain Reaction and immunohistochemistry confirmed their differential expression, underscoring their significance in PCPG diagnosis and in predicting immunotherapy response. This study\u2019s integration of amino acid metabolism-related genes into a risk prediction model offers critical clinical insights for PCPG risk stratification, potential immunotherapy responses, drug development, and treatment planning, marking a significant step forward in the management of this complex condition.<\/jats:p>","DOI":"10.1007\/s10528-024-10733-5","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T11:02:16Z","timestamp":1711364536000},"page":"850-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Constructing a Novel Amino Acid Metabolism Signature: A New Perspective on Pheochromocytoma Diagnosis, Immune Landscape, and Immunotherapy"],"prefix":"10.1007","volume":"63","author":[{"given":"Zechen","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkun","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonghu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"10733_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K et al (2021) Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39:845-865.e7. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.014","journal-title":"Cancer Cell"},{"key":"10733_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111429","volume":"40","author":"R Bajaj","year":"2022","unstructured":"Bajaj R, Rodriguez BL, Russell WK et al (2022) Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis. Cell Rep 40:111429. https:\/\/doi.org\/10.1016\/j.celrep.2022.111429","journal-title":"Cell Rep"},{"key":"10733_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.metabol.2017.11.005","volume":"81","author":"J Ben\u00edtez","year":"2018","unstructured":"Ben\u00edtez J, Garc\u00eda D, Romero N et al (2018) Metabolic strategies for the degradation of the neuromodulator agmatine in mammals. Metabolism 81:35\u201344. https:\/\/doi.org\/10.1016\/j.metabol.2017.11.005","journal-title":"Metabolism"},{"key":"10733_CR4","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.18632\/oncotarget.6402","volume":"7","author":"K Chandran","year":"2016","unstructured":"Chandran K, Goswami S, Sharma-Walia N (2016) Implications of a peroxisome proliferator-activated receptor alpha (PPAR\u03b1) ligand clofibrate in breast cancer. Oncotarget 7:15577\u201315599. https:\/\/doi.org\/10.18632\/oncotarget.6402","journal-title":"Oncotarget"},{"key":"10733_CR5","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.18632\/aging.102744","volume":"12","author":"D Chen","year":"2020","unstructured":"Chen D, Liu Q, Cao G, Zhang W (2020) TYRO3 facilitates cell growth and metastasis via activation of the Wnt\/\u03b2-catenin signaling pathway in human gastric cancer cells. Aging 12:2261\u20132274. https:\/\/doi.org\/10.18632\/aging.102744","journal-title":"Aging"},{"key":"10733_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14:108\u2013119. https:\/\/doi.org\/10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"key":"10733_CR7","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.7150\/ijbs.33790","volume":"15","author":"S Di","year":"2019","unstructured":"Di S, Fan C, Ma Z et al (2019) PERK\/eIF-2\u03b1\/CHOP pathway dependent ROS generation mediates butein-induced non-small-cell lung cancer apoptosis and G2\/M phase arrest. Int J Biol Sci 15:1637\u20131653. https:\/\/doi.org\/10.7150\/ijbs.33790","journal-title":"Int J Biol Sci"},{"key":"10733_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991\u2013998. https:\/\/doi.org\/10.1038\/ni1102-991","journal-title":"Nat Immunol"},{"key":"10733_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1472-8206.2009.00665.x","volume":"23","author":"R Eang","year":"2009","unstructured":"Eang R, Girbal-Neuhauser E, Xu B, Gairin JE (2009) Characterization and differential expression of a newly identified phosphorylated isoform of the human 20S proteasome \u03b27 subunit in tumor vs. normal cell lines. Fundam Clin Pharmacol 23:215\u2013224. https:\/\/doi.org\/10.1111\/j.1472-8206.2009.00665.x","journal-title":"Fundam Clin Pharmacol"},{"key":"10733_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","volume":"31","author":"M Fassnacht","year":"2020","unstructured":"Fassnacht M, Assie G, Baudin E et al (2020) Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO\u2013EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:1476\u20131490. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2099","journal-title":"Ann Oncol"},{"key":"10733_CR11","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1016\/j.clcc.2019.08.004","volume":"18","author":"L Fornaro","year":"2019","unstructured":"Fornaro L, Leone F, Vienot A et al (2019) Validated nomogram predicting 6-month survival in pancreatic cancer patients receiving first-line 5-fluorouracil, oxaliplatin, and irinotecan. Clin Colorectal Cancer 18:e394\u2013e401. https:\/\/doi.org\/10.1016\/j.clcc.2019.08.004","journal-title":"Clin Colorectal Cancer"},{"key":"10733_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W et al (2020) Large-scale public data reuse to model immunotherapy response and resistance. Genome Med 12:21. https:\/\/doi.org\/10.1186\/s13073-020-0721-z","journal-title":"Genome Med"},{"key":"10733_CR13","doi-asserted-by":"publisher","first-page":"T283","DOI":"10.1530\/ERC-17-0146","volume":"24","author":"S Gasser","year":"2017","unstructured":"Gasser S, Lim LHK, Cheung FSG (2017) The role of the tumour microenvironment in immunotherapy. Endocr Relat Cancer 24:T283\u2013T295. https:\/\/doi.org\/10.1530\/ERC-17-0146","journal-title":"Endocr Relat Cancer"},{"key":"10733_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/381166a0","volume":"381","author":"M Groettrup","year":"1996","unstructured":"Groettrup M, Soza A, Eggers M et al (1996) A role for the proteasome regulator PA28\u03b1 in antigen presentation. Nature 381:166\u2013168. https:\/\/doi.org\/10.1038\/381166a0","journal-title":"Nature"},{"key":"10733_CR15","doi-asserted-by":"publisher","first-page":"13723","DOI":"10.1038\/s41598-017-14216-z","volume":"7","author":"FS Guerra","year":"2017","unstructured":"Guerra FS, de Oliveira RG, Fraga CAM et al (2017) ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells. Sci Rep 7:13723. https:\/\/doi.org\/10.1038\/s41598-017-14216-z","journal-title":"Sci Rep"},{"key":"10733_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309\u2013322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022","journal-title":"Cancer Cell"},{"key":"10733_CR17","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/2326-6066.CIR-19-0008","volume":"7","author":"A Holtzhausen","year":"2019","unstructured":"Holtzhausen A, Harris W, Ubil E et al (2019) TAM family receptor kinase inhibition reverses MDSC-mediated suppression and augments anti\u2013PD-1 therapy in melanoma. Cancer Immunol Res 7:1672\u20131686. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0008","journal-title":"Cancer Immunol Res"},{"key":"10733_CR18","doi-asserted-by":"publisher","first-page":"15867","DOI":"10.1038\/s41598-019-52416-x","volume":"9","author":"H Houhou","year":"2019","unstructured":"Houhou H, Puckelwaldt O, Strube C, Haeberlein S (2019) Reference gene analysis and its use for kinase expression profiling in Fasciola hepatica. Sci Rep 9:15867. https:\/\/doi.org\/10.1038\/s41598-019-52416-x","journal-title":"Sci Rep"},{"key":"10733_CR19","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/cncr.23812","volume":"113","author":"H Huang","year":"2008","unstructured":"Huang H, Abraham J, Hung E et al (2008) Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 113:2020\u20132028. https:\/\/doi.org\/10.1002\/cncr.23812","journal-title":"Cancer"},{"key":"10733_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971045","volume":"13","author":"Y Kaminskiy","year":"2022","unstructured":"Kaminskiy Y, Kuznetsova V, Kudriaeva A et al (2022) Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion. Front Immunol 13:971045. https:\/\/doi.org\/10.3389\/fimmu.2022.971045","journal-title":"Front Immunol"},{"key":"10733_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13046-022-02420-3","volume":"41","author":"BK Kim","year":"2022","unstructured":"Kim BK, Kim DM, Park H et al (2022) Synaptotagmin 11 scaffolds MKK7\u2013JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis. J Exp Clin Cancer Res 41:212. https:\/\/doi.org\/10.1186\/s13046-022-02420-3","journal-title":"J Exp Clin Cancer Res"},{"key":"10733_CR22","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/sj.bjc.6605654","volume":"102","author":"CK Kontos","year":"2010","unstructured":"Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A (2010) Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 102:1384\u20131390. https:\/\/doi.org\/10.1038\/sj.bjc.6605654","journal-title":"Br J Cancer"},{"key":"10733_CR23","doi-asserted-by":"publisher","first-page":"E267","DOI":"10.1111\/j.1464-410X.2012.11152.x","volume":"110","author":"G Koutalellis","year":"2012","unstructured":"Koutalellis G, Stravodimos K, Avgeris M et al (2012) L-dopa decarboxylase (DDC ) gene expression is related to outcome in patients with prostate cancer: DDC in prognosis after radical prostatectomy. BJU Int 110:E267\u2013E273. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11152.x","journal-title":"BJU Int"},{"key":"10733_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK (2017) Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol 28:213\u2013227. https:\/\/doi.org\/10.1007\/s12022-017-9484-5","journal-title":"Endocr Pathol"},{"key":"10733_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-019-0106-z","volume":"19","author":"H Lemos","year":"2019","unstructured":"Lemos H, Huang L, Prendergast GC, Mellor AL (2019) Immune control by amino acid catabolism during tumorigenesis and therapy. Nat Rev Cancer 19:162\u2013175. https:\/\/doi.org\/10.1038\/s41568-019-0106-z","journal-title":"Nat Rev Cancer"},{"key":"10733_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. The Lancet 366:665\u2013675. https:\/\/doi.org\/10.1016\/S0140-6736(05)67139-5","journal-title":"The Lancet"},{"key":"10733_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H (2016) Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci 73:377\u2013392. https:\/\/doi.org\/10.1007\/s00018-015-2070-4","journal-title":"Cell Mol Life Sci"},{"key":"10733_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J (2020) Amino acids in cancer. Exp Mol Med 52:15\u201330. https:\/\/doi.org\/10.1038\/s12276-020-0375-3","journal-title":"Exp Mol Med"},{"key":"10733_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12935-023-03091-6","volume":"23","author":"T Liu","year":"2023","unstructured":"Liu T, Ren Y, Wang Q et al (2023) Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. Cancer Cell Int 23:259. https:\/\/doi.org\/10.1186\/s12935-023-03091-6","journal-title":"Cancer Cell Int"},{"key":"10733_CR30","doi-asserted-by":"publisher","first-page":"10930","DOI":"10.1038\/s41598-019-47248-8","volume":"9","author":"S Lompard\u00eda","year":"2019","unstructured":"Lompard\u00eda S, D\u00edaz M, Pibuel M et al (2019) Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines. Sci Rep 9:10930. https:\/\/doi.org\/10.1038\/s41598-019-47248-8","journal-title":"Sci Rep"},{"key":"10733_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/antiox11061128","volume":"11","author":"M Luo","year":"2022","unstructured":"Luo M, Zhou L, Huang Z et al (2022) Antioxidant therapy in cancer: rationale and progress. Antioxidants 11:1128. https:\/\/doi.org\/10.3390\/antiox11061128","journal-title":"Antioxidants"},{"key":"10733_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"10733_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG et al (2017) Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol 14:11\u201331. https:\/\/doi.org\/10.1038\/nrclinonc.2016.60","journal-title":"Nat Rev Clin Oncol"},{"key":"10733_CR34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1517\/17425255.2015.1027684","volume":"11","author":"S Matsusaka","year":"2015","unstructured":"Matsusaka S, Lenz HJ (2015) Pharmacogenomics of fluorouracil-based chemotherapy toxicity. Expert Opin Drug Metab Toxicol 11:811\u2013821. https:\/\/doi.org\/10.1517\/17425255.2015.1027684","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10733_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2009.05.028","volume":"286","author":"DO Moon","year":"2009","unstructured":"Moon DO, Kim MO, Lee JD et al (2009) Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett 286:172\u2013179. https:\/\/doi.org\/10.1016\/j.canlet.2009.05.028","journal-title":"Cancer Lett"},{"key":"10733_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy T, Cordes T, Handzlik MK et al (2020) Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature 586:790\u2013795. https:\/\/doi.org\/10.1038\/s41586-020-2609-x","journal-title":"Nature"},{"key":"10733_CR37","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","volume":"98","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Shima T, Saeki A et al (2007) Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 98:874\u2013881. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00470.x","journal-title":"Cancer Sci"},{"key":"10733_CR38","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1806651","volume":"381","author":"HPH Neumann","year":"2019","unstructured":"Neumann HPH, Young WF, Eng C (2019) Pheochromocytoma and Paraganglioma. N Engl J Med 381:552\u2013565. https:\/\/doi.org\/10.1056\/NEJMra1806651","journal-title":"N Engl J Med"},{"key":"10733_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010","journal-title":"Immunity"},{"key":"10733_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cancers11040436","volume":"11","author":"Y Pang","year":"2019","unstructured":"Pang Y, Liu Y, Pacak K, Yang C (2019) Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies. Cancers 11:436. https:\/\/doi.org\/10.3390\/cancers11040436","journal-title":"Cancers"},{"key":"10733_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2020.12.009","volume":"33","author":"G Pathria","year":"2021","unstructured":"Pathria G, Ronai ZA (2021) Harnessing the Co-vulnerabilities of amino acid-restricted cancers. Cell Metab 33:9\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.009","journal-title":"Cell Metab"},{"key":"10733_CR42","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"10733_CR43","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/pr8000892","volume":"7","author":"J Rho","year":"2008","unstructured":"Rho J, Qin S, Wang JY, Roehrl MHA (2008) Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res 7:2959\u20132972. https:\/\/doi.org\/10.1021\/pr8000892","journal-title":"J Proteome Res"},{"key":"10733_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102213","volume":"49","author":"CM Schaupp","year":"2022","unstructured":"Schaupp CM, Botta D, White CC et al (2022) Persistence of improved glucose homeostasis in Gclm null mice with age and cadmium treatment. Redox Biol 49:102213. https:\/\/doi.org\/10.1016\/j.redox.2021.102213","journal-title":"Redox Biol"},{"key":"10733_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG (2020) Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell 37:147\u2013156. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.011","journal-title":"Cancer Cell"},{"key":"10733_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","volume":"13","author":"MJ Smyth","year":"2016","unstructured":"Smyth MJ, Ngiow SF, Ribas A, Teng MWL (2016) Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 13:143\u2013158. https:\/\/doi.org\/10.1038\/nrclinonc.2015.209","journal-title":"Nat Rev Clin Oncol"},{"key":"10733_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cmet.2018.08.013","volume":"29","author":"SM Son","year":"2019","unstructured":"Son SM, Park SJ, Lee H et al (2019) Leucine signals to mTORC1 via its metabolite acetyl-coenzyme A. Cell Metab 29:192-201.e7. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.013","journal-title":"Cell Metab"},{"key":"10733_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S (2017) Regulatory T cells in cancer immunotherapy. Cell Res 27:109\u2013118. https:\/\/doi.org\/10.1038\/cr.2016.151","journal-title":"Cell Res"},{"key":"10733_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/imt-2016-0118","volume":"9","author":"E Timosenko","year":"2017","unstructured":"Timosenko E, Hadjinicolaou AV, Cerundolo V (2017) Modulation of cancer-specific immune responses by amino acid degrading enzymes. Immunotherapy 9:83\u201397. https:\/\/doi.org\/10.2217\/imt-2016-0118","journal-title":"Immunotherapy"},{"key":"10733_CR50","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.3390\/ijms21249565","volume":"21","author":"E Tremmel","year":"2020","unstructured":"Tremmel E, Kuhn C, Kaltofen T et al (2020) L-dopa-decarboxylase (DDC) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (MCF7 and T47D) growth in vitro according to their different expression of Gi- protein- coupled receptors. Int J Mol Sci 21:9565. https:\/\/doi.org\/10.3390\/ijms21249565","journal-title":"Int J Mol Sci"},{"key":"10733_CR51","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.21873\/anticanres.14572","volume":"40","author":"C Uejima","year":"2020","unstructured":"Uejima C, Morimoto M, Yamamoto M et al (2020) Prognostic significance of TYRO3 receptor tyrosine kinase expression in gastric cancer. Anticancer Res 40:5593\u20135600. https:\/\/doi.org\/10.21873\/anticanres.14572","journal-title":"Anticancer Res"},{"key":"10733_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA (2020) New aspects of amino acid metabolism in cancer. Br J Cancer 122:150\u2013156. https:\/\/doi.org\/10.1038\/s41416-019-0620-5","journal-title":"Br J Cancer"},{"key":"10733_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson RL, Chantranupong L, Saxton RA et al (2016) Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351:43\u201348. https:\/\/doi.org\/10.1126\/science.aab2674","journal-title":"Science"},{"key":"10733_CR54","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D (2021) Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat Rev Drug Discov 20:509\u2013530. https:\/\/doi.org\/10.1038\/s41573-021-00159-8","journal-title":"Nat Rev Drug Discov"},{"key":"10733_CR55","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nat Commun"},{"key":"10733_CR56","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/s41467-018-06461-1","volume":"9","author":"H Zhang","year":"2018","unstructured":"Zhang H, Wang Y, Li J et al (2018) Biosynthetic energy cost for amino acids decreases in cancer evolution. Nat Commun 9:4124. https:\/\/doi.org\/10.1038\/s41467-018-06461-1","journal-title":"Nat Commun"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10733-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10733-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10733-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T22:58:29Z","timestamp":1739833109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10733-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10733"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10733-5","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study was reviewed and approved by the ethics committee of The First Affiliated Hospital of Zhengzhou University (2022-KY-0209-002).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}